We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Everest Group
EG
$14B
| $935K | ﹤0.01% |
2,386
-698
| -23% | -$266K |
|
977
Lucid Motors
LCID
$2.54B
| $935K | ﹤0.01% |
26,490
+4,080
| +18% | +$142K |
|
|
FOLD
978
DELISTED
Amicus Therapeutics
FOLD
| $934K | ﹤0.01% |
87,441
+11,500
| +15% | +$125K |
|
979
Herc Holdings
HRI
$5.64B
| $934K | ﹤0.01% |
5,858
| – | – |
|
980
Tandem Diabetes Care
TNDM
$1.61B
| $933K | ﹤0.01% |
22,000
+4,400
| +25% | +$187K |
|
981
Veracyte
VCYT
$3.42B
| $933K | ﹤0.01% |
27,406
+5,400
| +25% | +$152K |
|
982
Blackstone Mortgage Trust
BXMT
$2.44B
| $923K | ﹤0.01% |
48,551
+14,600
| +43% | +$268K |
|
983
Hilton Grand Vacations
HGV
$3.49B
| $923K | ﹤0.01% |
25,409
+8,600
| +51% | +$333K |
|
984
FormFactor
FORM
$10.3B
| $918K | ﹤0.01% |
19,960
-1,500
| -7% | -$74.8K |
|
985
Blackbaud
BLKB
$2.1B
| $917K | ﹤0.01% |
10,830
+3,100
| +40% | +$247K |
|
|
WCN
986
Waste Connections
WCN
$41.6B
| $917K | ﹤0.01% |
5,129
-489
| -9% | -$88.5K |
|
987
PTC Therapeutics
PTCT
$6.01B
| $916K | ﹤0.01% |
24,700
+2,500
| +11% | +$83.7K |
|
|
PPLI
988
People Inc
PPLI
$3.01B
| $910K | ﹤0.01% |
20,601
+2,804
| +16% | +$117K |
|
989
J&J Snack Foods
JJSF
$1.7B
| $909K | ﹤0.01% |
5,279
+1,300
| +33% | +$218K |
|
990
Texas Capital Bancshares
TCBI
$4.38B
| $909K | ﹤0.01% |
12,723
+4,100
| +48% | +$268K |
|
991
Macy's
M
$6.27B
| $908K | ﹤0.01% |
57,865
+8,400
| +17% | +$136K |
|
992
American Eagle Outfitters
AEO
$2.73B
| $902K | ﹤0.01% |
40,292
| – | – |
|
993
Bank OZK
OZK
$5.7B
| $895K | ﹤0.01% |
20,825
| – | – |
|
994
Xenon Pharmaceuticals
XENE
$6.21B
| $894K | ﹤0.01% |
22,700
+1,700
| +8% | +$68.5K |
|
995
DXC Technology
DXC
$1.79B
| $882K | ﹤0.01% |
42,500
+6,100
| +17% | +$121K |
|
|
ECHO
996
EchoStar
ECHO
$26.6B
| $882K | ﹤0.01% |
35,542
+14,800
| +71% | +$303K |
|
997
Stevanato
STVN
$5.88B
| $876K | ﹤0.01% |
43,800
| – | – |
|
998
First Bancorp
FBP
$4.49B
| $875K | ﹤0.01% |
41,331
+10,200
| +33% | +$207K |
|
999
Kohl's
KSS
$2.22B
| $873K | ﹤0.01% |
41,394
| – | – |
|
1000
WD-40
WDFC
$3.09B
| $868K | ﹤0.01% |
3,365
+300
| +10% | +$75.2K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.